Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

CHO

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Integrating Cell Line and CMC Development

Cell Line Development

Integrating Cell Line and CMC Development

Stephen Hamilton, Ph.D.; Mike Brem

Wheeler Bio

PAO-06-022-CL-12Sep 02, 2022

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

evitria AG

PAO-03-022-CL-22Mar 22, 2022

Batavia Biosciences to Deploy Horizon Discovery’s CHO Cell Technology to Develop Anti-Zika Biotherapeutic

Zika

Batavia Biosciences to Deploy Horizon Discovery’s CHO Cell Technology to Develop Anti-Zika Biotherapeutic

Nice Insight

PR-M09-19-NI-019Sep 09, 2019